176 related articles for article (PubMed ID: 9043743)
1. Regional HmPAO SPECT and CT measurements in the diagnosis of Alzheimer's disease.
Mattman A; Feldman H; Forster B; Li D; Szasz I; Beattie BL; Schulzer M
Can J Neurol Sci; 1997 Feb; 24(1):22-8. PubMed ID: 9043743
[TBL] [Abstract][Full Text] [Related]
2. Accurate prediction of histologically confirmed Alzheimer's disease and the differential diagnosis of dementia: the use of NINCDS-ADRDA and DSM-III-R criteria, SPECT, X-ray CT, and APO E4 medial temporal lobe dementias. The Oxford Project to Investigate Memory and Aging.
Jobst KA; Barnetson LP; Shepstone BJ
Int Psychogeriatr; 1997; 9 Suppl 1():191-222; discussion 247-52. PubMed ID: 9447442
[TBL] [Abstract][Full Text] [Related]
3. Accurate prediction of histologically confirmed Alzheimer's disease and the differential diagnosis of dementia: the use of NINCDS-ADRDA and DSM-III-R criteria, SPECT, X-ray CT, and Apo E4 in medial temporal lobe dementias. Oxford Project to Investigate Memory and Aging.
Jobst KA; Barnetson LP; Shepstone BJ
Int Psychogeriatr; 1998 Sep; 10(3):271-302. PubMed ID: 9785148
[TBL] [Abstract][Full Text] [Related]
4. The diagnostic value of SPECT with Tc 99m HMPAO in Alzheimer's disease: a population-based study.
Claus JJ; van Harskamp F; Breteler MM; Krenning EP; de Koning I; van der Cammen TJ; Hofman A; Hasan D
Neurology; 1994 Mar; 44(3 Pt 1):454-61. PubMed ID: 8145915
[TBL] [Abstract][Full Text] [Related]
5. Parametric mapping of cerebral blood flow deficits in Alzheimer's disease: a SPECT study using HMPAO and image standardization technique.
Imran MB; Kawashima R; Awata S; Sato K; Kinomura S; Ono S; Yoshioka S; Sato M; Fukuda H
J Nucl Med; 1999 Feb; 40(2):244-9. PubMed ID: 10025830
[TBL] [Abstract][Full Text] [Related]
6. Abnormalities in rCBF and computed tomography in patients with Alzheimer's disease and in controls.
Wyper D; Teasdale E; Patterson J; Montaldi D; Brown D; Hunter R; Graham D; McCulloch J
Br J Radiol; 1993 Jan; 66(781):23-7. PubMed ID: 8428246
[TBL] [Abstract][Full Text] [Related]
7. Sensitivity, specificity, and positive predictive value of technetium 99-HMPAO SPECT in discriminating Alzheimer's disease from other dementias.
Masterman DL; Mendez MF; Fairbanks LA; Cummings JL
J Geriatr Psychiatry Neurol; 1997 Jan; 10(1):15-21. PubMed ID: 9100154
[TBL] [Abstract][Full Text] [Related]
8. Heterogeneity of neocortical cerebral blood flow deficits in dementia of the Alzheimer type: a [99mTc]-d,l-HMPAO SPECT study.
Waldemar G; Bruhn P; Kristensen M; Johnsen A; Paulson OB; Lassen NA
J Neurol Neurosurg Psychiatry; 1994 Mar; 57(3):285-95. PubMed ID: 8158175
[TBL] [Abstract][Full Text] [Related]
9. Regional cerebral blood flow measured by 99mTc-HMPAO SPECT differs in subgroups of Alzheimer's disease.
Soininen H; Helkala EL; Kuikka J; Hartikainen P; Lehtovirta M; Riekkinen PJ
J Neural Transm Park Dis Dement Sect; 1995; 9(2-3):95-109. PubMed ID: 8527009
[TBL] [Abstract][Full Text] [Related]
10. Technetium HMPAO SPECT study in dementia with Lewy bodies, Alzheimer's disease and idiopathic Parkinson's disease.
Defebvre LJ; Leduc V; Duhamel A; Lecouffe P; Pasquier F; Lamy-Lhullier C; Steinling M; Destée A
J Nucl Med; 1999 Jun; 40(6):956-62. PubMed ID: 10452310
[TBL] [Abstract][Full Text] [Related]
11. Assessment of cerebral perfusion with single-photon emission tomography in normal subjects and in patients with Alzheimer's disease: effects of region of interest selection.
Claus JJ; van Harskamp F; Breteler MM; Krenning EP; van der Cammen TJ; Hofman A; Hasan D
Eur J Nucl Med; 1994 Oct; 21(10):1044-51. PubMed ID: 7828613
[TBL] [Abstract][Full Text] [Related]
12. Longitudinal changes in cognitive function and regional cerebral function in Alzheimer's disease: a SPECT blood flow study.
Brown DR; Hunter R; Wyper DJ; Patterson J; Kelly RC; Montaldi D; McCullouch J
J Psychiatr Res; 1996; 30(2):109-26. PubMed ID: 8816305
[TBL] [Abstract][Full Text] [Related]
13. The diagnostic value of magnetic resonance imaging and technetium 99m-HMPAO single-photon-emission computed tomography for the diagnosis of Alzheimer disease in a community-dwelling elderly population.
Scheltens P; Launer LJ; Barkhof F; Weinstein HC; Jonker C
Alzheimer Dis Assoc Disord; 1997 Jun; 11(2):63-70. PubMed ID: 9194952
[TBL] [Abstract][Full Text] [Related]
14. Comparison of technetium-99m-HMPAO and technetium-99m-ECD cerebral SPECT images in Alzheimer's disease.
van Dyck CH; Lin CH; Smith EO; Wisniewski G; Cellar J; Robinson R; Narayan M; Bennett A; Delaney RC; Bronen RA; Hoffer PB
J Nucl Med; 1996 Nov; 37(11):1749-55. PubMed ID: 8917168
[TBL] [Abstract][Full Text] [Related]
15. [Molecular neuroimaging in the study of cognitive impairment: contribution of the cerebral blood flow SPECT with 99mTc-HMPAO and 18F-FDG PET/CT scan].
Banzo I; Quirce R; Martínez-Rodríguez I; Jiménez-Bonilla J; Portilla-Quattrociocchi H; Medina-Quiroz P; Ortega F; Rodríguez E; Mateo I; Vázquez-Higuera JL; de Arcocha M; Carril JM
Rev Esp Med Nucl; 2011; 30(5):301-6. PubMed ID: 21640440
[TBL] [Abstract][Full Text] [Related]
16. The value of HMPAO SPECT scanning in the diagnosis of early Alzheimer's disease in patients attending a memory clinic.
McMurdo ME; Grant DJ; Kennedy NS; Gilchrist J; Findlay D; McLennan JM
Nucl Med Commun; 1994 Jun; 15(6):405-9. PubMed ID: 8078635
[TBL] [Abstract][Full Text] [Related]
17. MRI-guided SPECT measurements of medial temporal lobe blood flow in Alzheimer's disease.
Julin P; Lindqvist J; Svensson L; Slomka P; Wahlund LO
J Nucl Med; 1997 Jun; 38(6):914-9. PubMed ID: 9189141
[TBL] [Abstract][Full Text] [Related]
18. Tc-99m HMPAO brain SPECT findings in mild and moderate Alzheimer's disease: correlation with event related potentials.
Gungor HA; Yildiz A; Aydin F; Gungor F; Boz A; Ozkaynak S
J Neurol Sci; 2005 Jul; 234(1-2):47-53. PubMed ID: 15950243
[TBL] [Abstract][Full Text] [Related]
19. HMPAO SPET and FDG PET in Alzheimer's disease and vascular dementia: comparison of perfusion and metabolic pattern.
Mielke R; Pietrzyk U; Jacobs A; Fink GR; Ichimiya A; Kessler J; Herholz K; Heiss WD
Eur J Nucl Med; 1994 Oct; 21(10):1052-60. PubMed ID: 7828614
[TBL] [Abstract][Full Text] [Related]
20. Quantification of functional deficit in Alzheimer's disease using a computer-assisted mapping program for 99mTc-HMPAO SPECT.
Karbe H; Kertesz A; Davis J; Kemp BJ; Prato FS; Nicholson RL
Neuroradiology; 1994; 36(1):1-6. PubMed ID: 8107986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
